TD Cowen reissued a “buy” rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Piper Sandler lowered their price target on ...

According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.

TD Cowen reiterated a “buy” rating and issued a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Bank of America upped ...

Ratings & Consensus Estimates: The consensus analyst rating on Tempus AI stock stands at a Buy currently with a price target of $59.60. TD Cowen, Loop Capital and Needham’s recent ratings imply ...

We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other ...

Tempus AI CFO Jim Rogers just sold over 31,000 shares ... In addition, analysts at TD Cowen have a buy rating on the TEM stock with a $74 price target. TEM is also expected to present at TD ...

In addition to Piper Sandler, Tempus AI, Inc. Class A also received a Hold from J.P. Morgan’s Rachel Vatnsdal in a report issued today. However, yesterday, TD Cowen maintained a Buy rating on ...

Benzinga's survey of 11 analysts shows a consensus price target of $60.44 for Tempus AI, but the most recent targets from Needham, JPMorgan, and TD Cowan average $66.33, meaning there is still ...

Epstein, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold 370 shares of the company's Class A Common Stock. The shares were sold on February 3, 2025, at an... Investing.com -- TD Cowen ...

On February 24, TipRanks reported that TD Cowen analyst Daniel Brennan reaffirmed a Buy rating on Tempus AI (NASDAQ:TEM) with ...